


Healthcare News Roundup: Generic
HSMN NewsFeed - 20 Sep 2016
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
HSMN NewsFeed - 25 Aug 2016
Teligent, Inc. Announces Health Canada Approval Of Three Baclofen Injection Products
Teligent, Inc. Announces Health Canada Approval Of Three Baclofen Injection Products
HSMN NewsFeed - 18 Aug 2016
Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development
Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development
